Natural History Study Protocol in PMM2-CDG (CDG-Ia)

Active, not recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Phosphomannomutase 2 Deficiency
Trial Locations (11)

19104

Children's Hospital of Philadelphia (CHOP), Philadelphia

55905

Mayo Clinic College of Medicine, Rochester

98105

Seattle Children's Hospital, Seattle

Unknown

University Hospital Leuven, Leuven

General University Hospital in Prague, Prague

Necker Enfants-Malades Hospital, Paris

University Hospital of Catania, Catania

Radboud University Nejmegen Medical Center, Nijmegen

Mother and Child Institute (Instytut Matki i Dziecka), Warsaw

Centro Hospitalar do Porto, Porto

Hospital Sant Joan de Déu, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glycomine, Inc.

INDUSTRY

NCT03173300 - Natural History Study Protocol in PMM2-CDG (CDG-Ia) | Biotech Hunter | Biotech Hunter